Topic

California

A collection of 427 issues

How to Get Amondys 45 (casimersen) Covered by Aetna (CVS Health) in California: Complete Requirements Guide 2025

Answer Box: Getting Amondys 45 Covered by Aetna (CVS Health) in California Fastest path to approval: Submit Aetna's precertification form with genetic test results confirming exon 45 amenable mutation, 6-minute walk test showing ≥300 meters, and specialist documentation before age 14. First step today: Call Aetna at 1-866-752-7021

UnitedHealthcare's Coverage Criteria for Lamzede (velmanase alfa-tycv) in California: What Counts as "Medically Necessary"?

Answer Box: Getting Lamzede Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Lamzede (velmanase alfa-tycv) through OptumRx Specialty Pharmacy. Medical necessity requires confirmed alpha-mannosidosis diagnosis with enzyme deficiency or MAN2B1 gene variants, plus documentation of functional impairment. If denied, California residents can file an Independent Medical Review (IMR)

If Rapivab (Peramivir) Isn't Approved by Cigna in California: Formulary Alternatives & Exception Paths

Answer Box: Quick Path to Influenza Treatment If Cigna denies Rapivab (peramivir), you have proven alternatives. Cigna typically requires patients try oral options like oseltamivir (Tamiflu) or zanamivir (Relenza) first through step therapy. If these fail or aren't suitable due to nausea, swallowing issues, or contraindications, request a

How to Get Nourianz (Istradefylline) Covered by Blue Cross Blue Shield in California: Forms, Appeals & Step Therapy Guide

Quick Answer: Getting Nourianz Covered by Blue Cross Blue Shield in California Blue Cross Blue Shield of California requires prior authorization for Nourianz (istradefylline), with step therapy mandating documented trials of two different adjunctive Parkinson's drug classes before approval. Submit requests through AuthAccel portal with comprehensive documentation of

How to Get Oxbryta (Voxelotor) Covered by Cigna in California: Appeals, Timelines & State Protections

Answer Box: Getting Oxbryta (Voxelotor) Coverage Important Update: Oxbryta (voxelotor) was withdrawn from the U.S. market in 2024 after FDA requested removal based on confirmatory evidence review. New prescriptions are typically denied due to loss of FDA approval. However, if you're currently on Oxbryta through continuity of

Get Ruconest (C1 Esterase Inhibitor) Covered by Cigna in California: Complete PA and Appeals Guide

Quick Answer: Cigna requires prior authorization for Ruconest (C1 esterase inhibitor [recombinant]) in California as of January 2025. You'll need HAE diagnosis confirmation, attack documentation, and prior therapy records. If denied, California's Independent Medical Review (IMR) overturns 50-68% of specialty drug denials. Start by gathering your

Requirements Checklist: Get Vyndaqel/Vyndamax (Tafamidis) Covered by Aetna CVS Health in California

Answer Box: Getting Tafamidis Coverage in California To get Vyndaqel/Vyndamax (tafamidis) covered by Aetna CVS Health in California: First, ensure you have confirmed ATTR-CM diagnosis with PYP scan Grade 2-3 uptake or cardiac biopsy, plus AL amyloidosis exclusion. Your cardiologist must submit prior authorization through Aetna's provider

How to Get Mavenclad (Cladribine) Covered by UnitedHealthcare in California: Complete Prior Authorization Guide with Appeal Scripts

Answer Box: Get Mavenclad Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Mavenclad (cladribine) in California through OptumRx. You'll need: confirmed relapsing MS diagnosis, documented failure of at least one other DMT, normal lymphocyte counts, and no pregnancy/malignancy. Submit via the UnitedHealthcare Provider Portal with

Myths vs. Facts: Getting Exondys 51 (Eteplirsen) Covered by Humana in California

Quick Answer: Exondys 51 Coverage by Humana in California Getting Exondys 51 (eteplirsen) covered by Humana requires prior authorization with strict genetic documentation—specifically proof of a DMD mutation amenable to exon 51 skipping. The fastest path: have your neurologist submit genetic test results, baseline functional assessments, and corticosteroid therapy

How to Renew Keytruda (Pembrolizumab) Approval with Humana in California: Timeline, Documentation, and Appeals

Quick Answer: Keytruda (pembrolizumab) renewal with Humana typically requires reauthorization every 6-12 months. Start 30-45 days before your current approval expires. Submit updated clinical documentation showing treatment response, tolerance, and continued medical necessity. If denied, California patients can appeal through Humana's internal process, then request an Independent Medical